Sector: Professional, Scientific, and Technical Services Industry: Research and Development in Biotechnology (except Nanobiotechnology)
26.75
0.58
(2.216%)
Volume:
73,946
52 week range:
17.52 - 43.81
Market Cap:
719.983M
Company Description:
founded in 2013 and based in san diego, calif., arcturus therapeutics is poised to become an industry leader in the application of rnai technologies for the treatment of disease and improved quality of life. the company’s aim is to develop breakthrough technology and novel therapeutics for rare diseases for which there is no adequate treatment. backed by a management team with extensive experience in the discovery and development of therapeutic modalities, arcturus is on the forefront of research and development of nanoparticle sirna drug delivery systems.